Loading...
XKRX007460
Market cap159mUSD
Jan 03, Last price  
784.00KRW
1D
1.55%
1Q
-33.11%
Jan 2017
-90.02%
Name

Aprogen Inc

Chart & Performance

D1W1MN
XKRX:007460 chart
P/E
—
P/S
1.56
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
69.38%
Rev. gr., 5y
24.15%
Revenues
150.58b
+92.19%
129,420,987,000273,131,523,000226,328,109,000232,257,161,000354,366,069,360170,688,128,220103,040,328,29076,535,323,00065,931,704,08054,835,625,52044,897,115,46051,047,023,34078,248,840,940127,142,624,220141,247,001,61078,349,308,040150,577,975,320
Net income
-55.62b
L-52.09%
6,906,158,0009,746,616,0004,397,799,000-13,632,123,000-52,545,647,000-12,073,669,000-51,128,204,30012,445,273,3503,391,320,1702,407,357,9502,340,781,200-32,108,236,00018,325,774,690-32,668,134,380-12,500,351,320-116,084,862,490-55,619,381,960
CFO
-58.16b
L-48.76%
-4,000,308,0003,615,903,0004,451,687,00019,777,262,0006,958,920,97024,572,470,550-6,400,724,26020,422,205,6501,173,191,9502,730,158,0808,074,245,600-1,489,226,630-1,115,654,26022,533,546,230-8,605,708,340-113,491,424,410-58,155,743,103
Dividend
Dec 27, 200737.5089 KRW/sh

Profile

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers. The company was formerly known as Aprogen KIC Inc. and changed its name to Aprogen Medicines Inc. April 2021. Aprogen Medicines Inc. was founded in 1971 and is based in Seongnam-si, South Korea.
URL
http://www.aprogen-kic.com/
IPO date
Jul 08, 1995
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
150,577,975
92.19%
78,349,308
-44.53%
Cost of revenue
198,429,609
151,718,503
Unusual Expense (Income)
NOPBT
(47,851,634)
(73,369,195)
NOPBT Margin
Operating Taxes
2,043,930
473,800
Tax Rate
NOPAT
(49,895,564)
(73,842,996)
Net income
(55,619,382)
-52.09%
(116,084,862)
828.65%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,514,758
(15,760,476)
BB yield
-2.43%
40.84%
Debt
Debt current
92,128,190
58,373,460
Long-term debt
33,136,775
33,327,899
Deferred revenue
8
Other long-term liabilities
13,435,809
11,773,455
Net debt
82,133,804
45,333,683
Cash flow
Cash from operating activities
(58,155,743)
(113,491,424)
CAPEX
(25,513,670)
(24,819,031)
Cash from investing activities
(43,452,495)
70,172,112
Cash from financing activities
94,296,082
70,804,380
FCF
14,793,529
(239,888,347)
Balance
Cash
40,684,413
47,459,501
Long term investments
2,446,748
(1,091,826)
Excess cash
35,602,262
42,450,210
Stockholders' equity
43,088,831
125,560,924
Invested Capital
519,938,084
520,516,892
ROIC
ROCE
EV
Common stock shares outstanding
236,171
67,462
Price
960.00
67.83%
572.00
-88.68%
Market cap
226,724,436
487.55%
38,588,171
-88.14%
EV
578,982,351
329,831,877
EBITDA
(18,821,658)
(44,976,816)
EV/EBITDA
Interest
1,764,606
9,905,644
Interest/NOPBT